about
Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so farCannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trialsEndocannabinoids in the retina: from marijuana to neuroprotectionHemopressin is an inverse agonist of CB1 cannabinoid receptorsNoradrenergic agonist administration into the central nucleus of the amygdala increases the tail-flick latency in lightly anesthetized rats.Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activationSelective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents.Recent data on cannabinoids and their pharmacological implications in neuropathic pain.The subjective psychoactive effects of oral dronabinol studied in a randomized, controlled crossover clinical trial for painIn vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liabilityCannabinoid CB1 receptor facilitation of substance P release in the rat spinal cord, measured as neurokinin 1 receptor internalization.Acute resistance exercise induces antinociception by activation of the endocannabinoid system in ratsMechanisms of exercise-induced hypoalgesia.Cannabinoid control of neuroinflammation related to multiple sclerosis.The endocannabinoid system and painEndocannabinoid modulation by FAAH and monoacylglycerol lipase within the analgesic circuitry of the periaqueductal greyThe psychiatric side-effects of rimonabant.Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects.The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complicationsThe effect of the palmitoylethanolamide analogue, palmitoylallylamide (L-29) on pain behaviour in rodent models of neuropathyWeighing the balance: how analgesics used in chronic pain influence sleep?Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the "Mirror Effect" of SchizophreniaEndocannabinoid system involvement in brain reward processes related to drug abuseSupraspinal modulation of pain by cannabinoids: the role of GABA and glutamateDrug design for neuropathic pain regulation from traditional Chinese medicineExamination of the Addictive and Behavioral Properties of Fatty Acid-Binding Protein Inhibitor SBFI26.PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidaseEndocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain.Modulating the endocannabinoid system in human health and disease--successes and failuresSynthesis and Preclinical Evaluation of Sulfonamido-based [(11)C-Carbonyl]-Carbamates and Ureas for Imaging Monoacylglycerol Lipase.Emerging drugs for cancer cachexia.Managing neuropathic pain with Sativex: a review of its pros and cons.Targeting the endocannabinoid system: to enhance or reduce?Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia.Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells.Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesiaEndocannabinoid-mediated control of synaptic transmission.Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.Interaction of the cannabinoid and opioid systems in the modulation of nociception.A spider derived peptide, PnPP-19, induces central antinociception mediated by opioid and cannabinoid systems.
P2860
Q21090468-FD115B3A-1F67-4E4B-AC8C-BECB3C78F394Q24625489-98835CBE-5910-46A9-A738-0B2B1133CDC8Q24656049-1685BD7F-FE0A-4E09-B69F-EA3C83130C40Q24683759-C7A39498-C865-4CC5-8F9D-BD3E4215ABC1Q30491178-DC670125-A283-431B-80B2-58419AF3427AQ30547823-C395C8F3-B964-44CA-9105-59504998EF7AQ30612936-F4F48289-39C9-4444-B641-BC427D48D2BAQ33527067-9F8EF1A2-AF54-430A-A3B2-818A5F82DAEBQ33578856-95F83E7D-6477-4BD5-8DCF-980EA1DCB20EQ33751118-4D79E7B4-4BCF-4214-BF8F-7D34C1B43AFEQ33803774-08CD99A1-BDE5-4A39-A21F-5776CB97F43FQ34071059-2F7B4F9E-9CA4-4A37-A135-8D21DC039E90Q34440671-1878E098-2F7D-49B9-80C8-0A75B7ECC5CCQ34583231-97D3DC06-AB08-4502-8723-38C89AF31B12Q34612917-1B8EE746-9719-485F-89E6-0FE780868957Q34953319-464FB158-FE1D-4CE8-83B7-700CDDC889F1Q34990771-55E92CFA-899B-40A2-9C9C-A20A1AD5BD31Q35822991-EEB12ACE-19D6-415E-9187-77602BC82D03Q35951992-17DD589B-BF42-45E6-982C-93D55B2E51A1Q36094329-5368D2B9-D7BA-40E8-95A1-91656AA8BB4AQ36110491-266CC60F-0FA1-435C-B58A-EADDE419CC46Q36275995-C9D6D7DD-CA62-49B5-9768-CF049A607D0EQ36357182-19CA5E26-D42E-4876-9AED-334868A51AA8Q36358712-21C0FC00-C043-4604-8267-04C4B1B47D7DQ36572904-3DEF8577-1011-46C5-A091-87E50C55DE5CQ36764791-0E42C5CB-8ABD-454C-A396-766AC3999C5AQ36797368-43D22099-C56D-4496-85B5-D0F0360BF3DCQ36912778-ED1FEAAF-16F8-4784-A8C2-553C8D58F296Q36933683-E55D918F-AC4E-4D85-AA38-4133199A9FD6Q36970368-02A02186-A2EF-4172-9E55-FDABD47CBD32Q36989913-BDD925C6-9487-4B1F-9F99-4BCEBFDC45D8Q37142074-90306980-1440-40AF-B4C3-EB3A27912F20Q37150745-4CCC5748-D7BD-44A3-B397-8D7AEFFD6F0BQ37216017-C1A268ED-7828-4314-A29A-5E17DCE84088Q37332431-1BD01C97-C7B1-4B4B-B7CC-813A5B6E89EEQ37345438-04969DE9-0A1B-4E07-AC09-DE6850062EA6Q37363621-A295DC5C-6575-403C-888A-842D3DC09F2BQ37371095-743BBDF5-F864-4751-AA21-DDB4F31CAF40Q37444813-FDD62C21-6C88-4AEA-97C6-D602F190462BQ37523119-8C909AF8-6C45-471C-A43C-AFC917D12583
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Endocannabinoid mechanisms of pain modulation
@ast
Endocannabinoid mechanisms of pain modulation
@en
type
label
Endocannabinoid mechanisms of pain modulation
@ast
Endocannabinoid mechanisms of pain modulation
@en
prefLabel
Endocannabinoid mechanisms of pain modulation
@ast
Endocannabinoid mechanisms of pain modulation
@en
P2860
P356
P1433
P1476
Endocannabinoid mechanisms of pain modulation
@en
P2093
Andrea G Hohmann
Richard L Suplita
P2860
P2888
P304
P356
10.1208/AAPSJ080479
P407
P577
2006-11-17T00:00:00Z
P5875
P6179
1011890660